Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Publication year range
1.
Acupunct Med ; 37(4): 252-258, 2019 08.
Article in English | MEDLINE | ID: mdl-31342771

ABSTRACT

BACKGROUND: Acupuncture stimulation at GV26 during the acute phase of cerebral ischaemia can effectively reduce brain damage induced by ischaemic injury. However, the time course of the effects of acupuncture stimulation has not yet been thoroughly studied. OBJECTIVE: To investigate the effects of manual acupuncture (MA) on glutamic acid (Glu) and γ-aminobutyric acid (GABA) expression in the cerebrospinal fluid of rats with middle cerebral artery occlusion (MCAO) and determine whether there is a temporal effect of acupuncture on the treatment of cerebral ischaemia. METHODS: We performed thread occlusion of the right middle cerebral artery in rats to establish an animal model of MCAO. Simultaneously, during acupuncture treatment, microdialysis was used to continuously and dynamically observe immediate alterations in amino acid metabolism with acupuncture stimulation after cerebral ischaemia in vivo in this rat model of MCAO. RESULTS: We found that, in comparison with an untreated MCAO group, Glu content was significantly decreased during the first acupuncture stimulation and during the course of the acupuncture treatment in the MCAO+MA group (MCAO vs MCAO+MA: day 1, P=0.032; day 2, P=0.021; day 3, P=0.017). These findings were also seen after the end of treatment when acupuncture was no longer applied (MCAO vs MCAO+MA: day 7, P=0.009). Measurements of GABA content following cerebral ischaemic injury showed that GABA peaks 24 hours after damage, falls thereafter and decreases to baseline levels on day 7. In the MCAO+MA group, GABA content on days 1 to day 2 was lower than in the MCAO group (MCAO+MA vs MCAO: day 1, P=0.003; day 2, P=0.001), although it was higher than in the control group (MCAO+MA vs control: day 1, P=0.024; day 2, P=0.009). GABA content on day 3 and day 7 was higher in the MCAO+MA group than in the MCAO group and the control group (MCAO+MA vs MCAO: day 3, P=0.008; day 7, P=0.013; MCAO+MA vs control: day 3, P=0.002; day 7, P=0.009). CONCLUSION: Acupuncture stimulation at GV26 can effectively decrease excessive release of Glu induced by ischaemia and maintain the endogenous inhibitory activity of GABA. This phenomenon was seen during the entire course of acupuncture treatment and continued for some time after the end of acupuncture treatment.


Subject(s)
Acupuncture Therapy , Brain Ischemia/therapy , Glutamic Acid/metabolism , gamma-Aminobutyric Acid/metabolism , Animals , Brain Ischemia/metabolism , Disease Models, Animal , Hippocampus/metabolism , Humans , Infarction, Middle Cerebral Artery/metabolism , Infarction, Middle Cerebral Artery/therapy , Male , Neurotransmitter Agents/metabolism , Rats , Rats, Sprague-Dawley
2.
Acta Crystallogr Sect E Struct Rep Online ; 66(Pt 1): m82, 2009 Dec 19.
Article in English | MEDLINE | ID: mdl-21579975

ABSTRACT

In the title compound, {[Pr(2)(C(2)O(4))(3)(H(2)O)(4)]·2H(2)O}(n), the three-dimensional network structure has the Pr(III) ion coordinated by nine O atoms in a distorted tricapped trigonal-prismatic geometry. The coordinated and uncoordinated water mol-ecules inter-act with the carboxyl-ate O atoms to consolidate the network via O-H⋯O hydrogen bonds.

3.
Chinese Journal of Hepatology ; (12): 37-39, 2003.
Article in Chinese | WPRIM (Western Pacific) | ID: wpr-276509

ABSTRACT

<p><b>OBJECTIVE</b>To prevent chronic severe hepatitis, even more fulminant hepatic failure (FHF) occurrence in patients with chronic hepatitis B of severe degree using steroid.</p><p><b>METHODS</b>120 patients were randomized into conventional supporting treatment and steroid treatment groups. The latter, 62 patients were given intravenously hydrocortisone sodium succinate at the dose of 150 mg to approximately 200 mg everyday plus support care.</p><p><b>RESULTS</b>The rate of deteriorating to chronic severe hepatitis in steroid treatment group was significantly lower than that of conventional group (22% vs 48%, x(2) =7.60, P<0.01). 53.6% (15/28) patients with chronic severe hepatitis in conventional group died, while only 28.6% (4/14) in steroid treatment group succumbed to terminal liver disease (x(2)=0.02, P>0.05). There was no difference between the two groups regarding to complications incidence: gastrointestinal bleeding and infections except for some controllable serious reverse events, such as candidiasis, diabetes, herpes zoster and pulmonary tuberculosis found in some patients in steroid-treated group.</p><p><b>CONCLUSION</b>These results suggest that steroid administration with improved support care not only is likely to prevent chronic severe hepatitis occurrence in patients with chronic viral hepatitis of severe degree, but also shows some efficacy for FHF, which warrant further investigation.</p>


Subject(s)
Adult , Female , Humans , Male , Glucocorticoids , Therapeutic Uses , Hepatitis B, Chronic , Drug Therapy , Liver Failure
SELECTION OF CITATIONS
SEARCH DETAIL
...